500O Trotabresib (CC-90010) combined with concomitant temozolomide (TMZ) plus radiotherapy (RT) and adjuvant TMZ in patients (pts) with newly diagnosed primary glioblastoma (ndGBM): Updated results from a phase Ib/II study

Temozolomide Concomitant
DOI: 10.1016/j.annonc.2023.09.1694 Publication Date: 2023-10-20T12:16:21Z